Constellium SE
NYSE:CSTMAluminum
+$0.32 today
- Market cap
- $2.88B
- Beta
- 1.54
- P/E (TTM)
- 10.7
- EPS (TTM)
- $3.17
Volume 1.46M
Average 2.27M
CSTM Net Receivables
Amounts owed to the company by customers and others, net of allowances for uncollectible accounts.
Constellium SENYSE: CSTM
Net Receivables · Q3 FY2026 · quarter ended Sep 2026
Net receivables rises 22.5% from a year ago
Net receivables stood at $1B at the end of Q3 FY2026, up 22.5% from a year earlier and down 14.1% from the prior quarter. Over 3 fiscal years it compounded at +8.4% a year.
Context
- Net receivables amounted to 17.1% of total assets at the end of Q3 FY2026, up 1.9 pp from a year earlier.
- Net receivables increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether net receivables keeps rising in the next quarterly balance sheet after a +22.5% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Net Receivables history
Mixed currencies · from the balance sheet
- Latest · FY2025
- 722.78M USD
- Year-over-year change
- —
| Period | Period end | Net Receivables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 722.78M | — |
| FY2024 | 2024-12-31 | 486M | +25.3% |
| FY2023 | 2023-12-31 | 388M | -31.5% |
| FY2022 | 2022-12-31 | 566.71M | -26.1% |
| FY2021 | 2021-12-31 | 766.47M | — |
Net Receivables vs competitors
How CSTM compares with its peers on the latest reported figures
- Peers report in different currencies, so net receivables is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of +22.5% is the 7th highest of 11, against a peer median of +29.4%.
- Net receivables amounts to 17.1% of total assets for CSTM, versus a peer median of 7.9%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | R$5.07B BRL | +19.2% | -7.4% | 5.2% | |
| Sep 2026 | $1B USD | +22.5% | +8.4% | 17.1% | |
| Jun 2026 | $988.6M USD | -7.9% | -2.0% | 13.3% | |
| Jun 2026 | $647.3M USD | +32.9% | +4.3% | 22.2% | |
| Sep 2026 | $482.32M USD | +4.2% | +2.1% | 14.1% | |
| Jun 2026 | ZAR 462.09M ZAR | +40.2% | +52.6% | 2.7% | |
| Sep 2026 | $324.9M USD | +145.0% | +69.7% | 10.2% | |
| Jul 2026 | $260.78M USD | +31.5% | +1.2% | 13.9% | |
| Jun 2026 | $256M USD | +27.4% | -15.6% | 5.6% | |
| Jun 2026 | $65.12M USD | -3.4% | +45.7% | 2.6% | |
| Jun 2026 | $60.94M USD | +107.1% | +14.6% | 2.8% | |
| Peer median (excluding CSTM) | — | +29.4% | +3.2% | 7.9% | |
Competitors are the stored peer set for CSTM. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 · EUR | FY2022 Dec 2022 · EUR | FY2023 Dec 2023 · EUR | FY2024 Dec 2024 · EUR | FY2025 Dec 2025 · USD |
|---|---|---|---|---|---|
| Cash & Equivalents | 167.17M | 177.16M | 180M | 141M | 119.96M |
| Short-term Investments | 0 | 0 | 30M | 0 | 0 |
| Net Receivables | 766.47M | 566.71M | 388M | 486M | 722.78M |
| Inventory | 1.19B | 1.41B | 1.1B | 1.18B | 1.41B |
| Other Current Assets | 65.96M | 33.08M | 116M | 26M | 71.98M |
| Total Current Assets | 2.2B | 2.19B | 1.82B | 1.83B | 2.32B |
| Property, Plant & Equipment (Net) | 2.22B | 2.15B | 2.05B | 2.41B | 2.58B |
| Goodwill | 512.88M | 510.15M | 462M | 46M | 46.99M |
| Intangible Assets | 65.96M | 57.63M | 47M | 97M | 87.97M |
| Long-term Investments | 47.76M | 38.42M | 2M | 38M | 41.99M |
| Tax Assets | 184.23M | 289.22M | 1.69M | 311M | 269.92M |
| Other Non-current Assets | 28.43M | 30.95M | 281.31M | 0 | 0 |
| Total Non-current Assets | 3.05B | 3.08B | 2.84B | 2.9B | 3.03B |
| Total Assets | 5.26B | 5.27B | 4.66B | 4.73B | 5.35B |
| Account Payables | 1.21B | 1.23B | 931M | 959M | 1.67B |
| Short-term Debt | 293.4M | 157.95M | 54M | 39M | 38.99M |
| Tax Payables | 34.02M | 15.96M | 19.02M | 18M | 0 |
| Deferred Revenue | 87.56M | 58.7M | 0 | 65M | 0 |
| Other Current Liabilities | 108.03M | 132.34M | 177M | 284M | 42.99M |
| Total Current Liabilities | 1.95B | 1.81B | 1.39B | 1.45B | 1.8B |
| Long-term Debt | 1.92B | 1.86B | 1.66B | 1.88B | 1.9B |
| Deferred Tax Liabilities | 15.92M | 29.88M | 28M | 39M | 69.98M |
| Deferred Revenue (Non-current) | 4.55M | 21.35M | (1.37M) | 0 | 0 |
| Other Non-current Liabilities | 830.16M | 576.32M | 565.63M | 643M | 609.81M |
| Total Non-current Liabilities | 2.98B | 2.66B | 2.41B | 2.56B | 2.58B |
| Total Liabilities | 4.93B | 4.47B | 3.8B | 4.01B | 4.38B |
| Common Stock | 3.41M | 3.2M | 3M | 4M | 4M |
| Retained Earnings | (173.99M) | 157.95M | 420M | 203M | 353.89M |
| Accumulated OCI | 4.55M | 170.76M | 146M | (14M) | 53.98M |
| Other Stockholders Equity | 0 | 0 | (146M) | 0 | 0 |
| Minority Interest | 19.33M | 22.41M | 21.02M | 21M | 18.99M |
| Total Equity | 330.93M | 802.57M | 864.02M | 727M | 970.7M |
| Total Debt | 2.42B | 2.19B | 1.87B | 1.94B | 1.94B |
| Net Debt | 2.25B | 2.02B | 1.69B | 1.79B | 1.82B |
Constellium SE
NYSE:CSTM
Intrinsic Alpha fair value
Locked
Current Price
$21.37
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.